Founded in 2011, Quarkmed is a CRO company with fine reputation and formed by intra- industrial experienced teams. Quarkmed has its headquarter in Beijing and branches and agencies in Shanghai, Guangzhou, Hangzhou, Chengdu, Wuhan, Zhengzhou, Shenyang and other regions, covering all- round business segments such as bioassay, innovative drug clinical study, generic drug clinical study, and data statistics, and can provide international registration services, covering regions including Europe, Australia, and North America. Quarkmed continuously explores the fusion of artificial intelligence and clinical study, and deepens the digital revolution of clinical management.

With the service concept “Grow Together, Success After”, Quarkmed focuses always on custom value. Over 12 years of development, the company has accumulated rich experience in nuclear medicine, cell and gene therapy, cardiovascular, tumor, neuropsychiatry, respiration and other fields. Never distracted by time and tide, Quarkmed has infinite faith in permanence, accompanying with sincere and boosting by professionalism.      

Up to date, Quarkmed has been assisting customers in obtaining multiple production approvals! Quarkmed has assisted more than 20 GCP hospitals in building phase I clinical trial centers and has established cooperation with more than 70 clinical institutions in recent years, focusing on value-added services covering the whole industry chain to lay a solid foundation for medical R & D as well as pharmaceutical R & D for manufacturing enterprises.